BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7902163)

  • 21. Homozygous and heterozygous inheritance of PAX3 mutations causes different types of Waardenburg syndrome.
    Wollnik B; Tukel T; Uyguner O; Ghanbari A; Kayserili H; Emiroglu M; Yuksel-Apak M
    Am J Med Genet A; 2003 Sep; 122A(1):42-5. PubMed ID: 12949970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in PAX3 that cause Waardenburg syndrome type I: ten new mutations and review of the literature.
    Baldwin CT; Hoth CF; Macina RA; Milunsky A
    Am J Med Genet; 1995 Aug; 58(2):115-22. PubMed ID: 8533800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic variation in Waardenburg syndrome: mutational heterogeneity, modifier genes or polygenic background?
    Pandya A; Xia XJ; Landa BL; Arnos KS; Israel J; Lloyd J; James AL; Diehl SR; Blanton SH; Nance WE
    Hum Mol Genet; 1996 Apr; 5(4):497-502. PubMed ID: 8845842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome.
    Baldwin CT; Hoth CF; Amos JA; da-Silva EO; Milunsky A
    Nature; 1992 Feb; 355(6361):637-8. PubMed ID: 1347149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A frameshift mutation in the HuP2 paired domain of the probable human homolog of murine Pax-3 is responsible for Waardenburg syndrome type 1 in an Indonesian family.
    Morell R; Friedman TB; Moeljopawiro S; Hartono ; Soewito ; Asher JH
    Hum Mol Genet; 1992 Jul; 1(4):243-7. PubMed ID: 1303193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis of splotch and Waardenburg Pax-3 mutations.
    Chalepakis G; Goulding M; Read A; Strachan T; Gruss P
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3685-9. PubMed ID: 7909605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A PAX3 polymorphism (T315K) in a family exhibiting Waardenburg Syndrome type 2.
    Wang C; Kim E; Attaie A; Smith TN; Wilcox ER; Lalwani AK
    Mol Cell Probes; 1998 Feb; 12(1):55-7. PubMed ID: 9584079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of MLPA in Waardenburg syndrome.
    Milunsky JM; Maher TA; Ito M; Milunsky A
    Genet Test; 2007; 11(2):179-82. PubMed ID: 17627390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three mutations in the paired homeodomain of PAX3 that cause Waardenburg syndrome type 1.
    Morell R; Carey ML; Lalwani AK; Friedman TB; Asher JH
    Hum Hered; 1997; 47(1):38-41. PubMed ID: 9017978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and functional analysis of a novel mutation in the PAX3 gene associated with Waardenburg syndrome type I.
    Niu Z; Li J; Tang F; Sun J; Wang X; Jiang L; Mei L; Chen H; Liu Y; Cai X; Feng Y; He C
    Gene; 2018 Feb; 642():362-366. PubMed ID: 29158168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype-phenotype correlations in type 1 Waardenburg syndrome.
    Lalwani AK; Mhatre AN; San Agustin TB; Wilcox ER
    Laryngoscope; 1996 Jul; 106(7):895-902. PubMed ID: 8667990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible homozygous Waardenburg syndrome in a fetus with exencephaly.
    Aymé S; Philip N
    Am J Med Genet; 1995 Nov; 59(2):263-5. PubMed ID: 8588597
    [No Abstract]   [Full Text] [Related]  

  • 33. A novel missense mutation of the paired box 3 gene in a Turkish family with Waardenburg syndrome type 1.
    Hazan F; Ozturk AT; Adibelli H; Unal N; Tukun A
    Mol Vis; 2013; 19():196-202. PubMed ID: 23378733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and clinical characterization of Waardenburg syndrome type I in an Iranian cohort with two novel PAX3 mutations.
    Jalilian N; Tabatabaiefar MA; Farhadi M; Bahrami T; Emamdjomeh H; Noori-Daloii MR
    Gene; 2015 Dec; 574(2):302-7. PubMed ID: 26275939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel mutation of the PAX3 gene in a Chinese family with Waardenburg syndrome type I.
    Ma J; Lin K; Jiang HC; Yang Y; Zhang Y; Yang G; Sun H; Ming C; Bi X; Zhang T; Ruan B
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00798. PubMed ID: 31190477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Pax3 modifier genes on craniofacial morphology, pigmentation, and viability: a murine model of Waardenburg syndrome variation.
    Asher JH; Harrison RW; Morell R; Carey ML; Friedman TB
    Genomics; 1996 Jun; 34(3):285-98. PubMed ID: 8786127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three cases of Waardenburg syndrome type 2 in a Korean family.
    Choi JH; Moon SK; Lee KH; Lew HM; Chang YH
    Korean J Ophthalmol; 2004 Dec; 18(2):185-9. PubMed ID: 15635834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAX3 mutations and clinical characteristics in Chinese patients with Waardenburg syndrome type 1.
    Wang J; Li S; Xiao X; Wang P; Guo X; Zhang Q
    Mol Vis; 2010 Jun; 16():1146-53. PubMed ID: 20664692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exclusion of RET and Pax 3 loci in Waardenburg-Hirschsprung disease.
    Attié T; Till M; Pelet A; Edery P; Bonnet JP; Munnich A; Lyonnet S
    J Med Genet; 1995 Apr; 32(4):312-3. PubMed ID: 7643365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and molecular genetic investigation of Waardenburg syndrome type 1].
    Markova TG; Megrelishvilli SM; Shevtsov SP; Shvarts EI
    Vestn Otorinolaringol; 2003; (1):17-9. PubMed ID: 12666593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.